For the year ending 2025-12-31, BEIGF made $5,343,033K in revenue. $286,933K in net income. Net profit margin of 5.37%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 5,343,033 | 3,779,546 | ||
| Cost of sales - product | - | 594,089 | ||
| Cost of sales - product-Product | 668,540 | - | ||
| Gross profit | 4,674,493 | 3,216,152 | ||
| Research and development | 2,145,868 | 1,953,295 | ||
| Selling, general and administrative | 2,081,489 | 1,831,056 | ||
| Total operating expenses | 4,227,357 | 3,784,351 | ||
| Income (loss) from operations | 447,136 | -568,199 | ||
| Interest income | 70,505 | - | ||
| Interest expense | 58,234 | - | ||
| Other (expense) income, net | -42,553 | -12,638 | ||
| Interest income, net | - | 47,836 | ||
| Income (loss) before income taxes | 416,854 | -533,001 | ||
| Income tax expense | 129,921 | 111,785 | ||
| Net income (loss) | 286,933 | -644,786 | ||
| Basic EPS | 0.2 | -0.47 | ||
| Diluted EPS | 0.19 | -0.47 | ||
| Basic Average Shares | 1,417,803,727 | 1,368,746,793 | ||
| Diluted Average Shares | 1,474,829,908 | 1,368,746,793 | ||
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)